Últimos resultados 4 ago 2026
Bayer AG NA
I · Análisis con IA
En breve
Bayer makes prescription medicines for heart disease, women's health, cancer, and blood disorders; sells consumer brands like Midol and Aspirin; and provides seeds, pesticides, and digital farming tools to agriculture customers worldwide [Yahoo Finance]. The Crop Science division is the largest profit contributor, generating nearly half of total revenue [Simply Wall St].
Bayer is a 161-year-old German life sciences giant operating three major divisions: prescription drugs (Pharmaceuticals), over-the-counter health products (Consumer Health), and agricultural seeds and crop chemicals (Crop Science) [Yahoo Finance]. The company currently reports a €2,2 billion net loss on €45,6 billion in revenue, but recent news signals potential recovery through two FDA priority-review drugs in stroke prevention and lung cancer [Yahoo Finance]. Bayer also faces ongoing environmental liabilities, including a recent $133 million settlement for PCB contamination cleanup [Seeking Alpha].
Bayer is currently unprofitable with moderate debt levels, but maintains strong gross margins and positive free cash flow [Yahoo Finance].
Puntuación Sentinellis
4,2/10
Riesgos significativos
Capitalización bursátil
EUR 37,8B
Ingresos (12 meses)
EUR 45,6B
Explicaciones
Cómo leemos estas cifras
Guías en lenguaje sencillo · sin cuenta
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LeerPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LeerAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LeerII · Noticias recientes
Qué movió el precio
6 noticias · ordenadas por relevancia
- Macro2026-05-20
BAYRY or RHHBY: Which Is the Better Value Stock Right Now?
Zacks
- Macro2026-05-20
Should FDA Priority Review for HYRNUO’s First-Line Lung Cancer Use Require Action From Bayer (XTRA:BAYN) Investors?
Yahoo Finance
- Macro2026-05-19
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
Yahoo Finance
- Macro2026-05-19
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Yahoo Finance
- Macro2026-05-19
FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
Yahoo Finance
- Macro2026-05-17
Assessing Bayer (XTRA:BAYN) Valuation After Mixed Share Performance And Profit Recovery Hopes
Simply Wall St
Premium · gratis con cualquier cuenta
Bayer reported a €2,2 billion net loss for the most recent fiscal year despite €45,6 billion in revenue, and the company remains unprofitable with a negative net margin of -7,9% [Yahoo Finance]
Riesgos
5
Oportunidades
5
Señales de alerta
3
Dirección
10
12 hallazgos más en el informe completo — gratis con cualquier cuenta.
Desbloquea el análisis completo de Bayer AG NA
Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.
- 5 riesgos, 5 oportunidades y 3 señales de alerta — cada uno con su fuente
- Más de 100 métricas financieras con gráficos y comparativas
- Resúmenes completos de noticias con enlaces a las fuentes
- Equipo directivo y remuneración
III · Empresas similares
También te puede interesar
Mismo sector · Salud — o salud financiera comparable
¿La añades a tu lista?